Immunai

immunai.com

Immunai is a biotech company focused on decoding the immune system through an AI model that facilitates the development of next-generation immunomodulatory therapeutics. By leveraging multi-omic single-cell analysis, machine learning, and functional genomics, Immunai addresses core challenges in drug development, including clinical trial optimization, preclinical asset evaluation, and target discovery. The company differentiates itself with a multidisciplinary team of experts and a unique engineering-first approach, aiming to bring breakthrough medicines to patients. With strategic partnerships with big pharma and research institutions, Immunai is positioned to advance novel therapeutics and accelerate R&D in the immunology space.